Name: Forte Biosciences, Inc. (FBRX) Balance Sheet
Creator: FinSpry

Forte Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Forte Biosciences, Inc. (FBRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	22.24	37.13	41.10	42.04	58.77
Short-Term Investments	36.12	25.16	0.00	0.00	0.00
Cash & Short-Term Investments	58.37	37.13	41.10	42.04	58.77
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.34	1.04	0.34	0.09	0.96
Total Current Assets	61.35	38.33	41.51	42.52	59.90
Non-Current Assets
Property, Plant & Equipment (Net)	0.08	0.11	0.00	0.00	0.10
Other Non-Current Assets	0.05	0.54	0.49	0.01	1.24
Total Non-Current Assets	0.22	0.65	0.49	0.79	1.34
Total Assets	61.56	38.98	42.00	43.31	61.24
Current Liabilities
Accounts Payable	4.88	1.42	1.15	0.95	2.26
Accrued Liabilities	2.65	2.24	2.03	0.13	1.02
Other Current Liabilities	4.20	0.00	0.00	0.00	0.00
Total Current Liabilities	9.08	3.67	3.18	1.76	2.26
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Liabilities	9.08	3.67	3.18	1.76	2.26
Stockholders' Equity
Common Stock	0.01	0.00	0.02	0.02	0.01
Retained Earnings	-154.00	-118.52	-87.04	-73.17	-51.46
Accumulated Other Comprehensive Income	0.01	0.00	0.00	0.00	0.00
Additional Paid-in Capital	206.46	153.83	125.84	114.70	110.42
Shares Outstanding	6.39	1.45	0.84	0.59	0.00
Total Stockholders' Equity	52.48	35.31	38.82	41.55	58.98
Total Liabilities & Equity	61.56	38.98	42.00	43.31	61.24